Source:http://linkedlifedata.com/resource/pubmed/id/18577448
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-11-21
|
pubmed:abstractText |
To reach its target cells, the antiepileptic drug valproate has to cross both the intestinal epithelial barrier and the blood-brain barrier in intact form as well as in sufficient amounts. This study was performed to characterize the epithelial transport of valproate at intestinal (Caco-2) and at blood-brain barrier (RBE4) cells. At both cell types, uptake of [(3)H]valproate was independent of inwardly directed Na(+), Ca(2+), Mg(2+), K(+) or Cl(-) gradients. Uptake was, however, strongly stimulated by an inwardly directed H(+) gradient. The cells accumulated valproate against a concentration gradient and the uptake rate of valproate was saturable with K(t) values of 0.6 and 0.8mM. At Caco-2 cell monolayers, the total apical-to-basolateral flux of [(3)H]valproate exceeded the basolateral-to-apical flux 14-fold. Various monocarboxylic acids like salicylate, benzoate, acetate, propionate, butyrate, hexanoate, diclofenac and ibuprofen inhibited [(3)H]valproate uptake at both cell types. Lactate and pyruvate inhibited valproate uptake at RBE4 cells but not at Caco-2 cells. We conclude that valproate is accumulated in intestinal cells against a concentration gradient by the activity of a specific H(+)-dependent DIDS-insensitive transport system for monocarboxylates not identical with monocarboxylate transporter 1 (MCT1). The passage of valproate across the blood-brain barrier is very likely mediated by MCT1.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants,
http://linkedlifedata.com/resource/pubmed/chemical/Monocarboxylic Acid Transporters,
http://linkedlifedata.com/resource/pubmed/chemical/Symporters,
http://linkedlifedata.com/resource/pubmed/chemical/Valproic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/monocarboxylate transport protein 1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0939-6411
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
486-92
|
pubmed:meshHeading |
pubmed-meshheading:18577448-Anticonvulsants,
pubmed-meshheading:18577448-Biological Transport,
pubmed-meshheading:18577448-Blood-Brain Barrier,
pubmed-meshheading:18577448-Brain,
pubmed-meshheading:18577448-Caco-2 Cells,
pubmed-meshheading:18577448-Endothelial Cells,
pubmed-meshheading:18577448-Humans,
pubmed-meshheading:18577448-Hydrogen-Ion Concentration,
pubmed-meshheading:18577448-Monocarboxylic Acid Transporters,
pubmed-meshheading:18577448-Substrate Specificity,
pubmed-meshheading:18577448-Symporters,
pubmed-meshheading:18577448-Valproic Acid
|
pubmed:year |
2008
|
pubmed:articleTitle |
Transport of valproate at intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells: mechanism and substrate specificity.
|
pubmed:affiliation |
Biozentrum, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|